Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.00
+0.29 (1.85%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Rallybio Employees
Rallybio had 14 employees as of December 31, 2025. The number of employees decreased by 11 or -44.00% compared to the previous year.
Employees
14
Change (1Y)
-11
Growth (1Y)
-44.00%
Revenue / Employee
$61,286
Profits / Employee
-$558,357
Market Cap
84.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14 | -11 | -44.00% |
| Dec 31, 2024 | 25 | -18 | -41.86% |
| Dec 31, 2023 | 43 | 2 | 4.88% |
| Dec 31, 2022 | 41 | 6 | 17.14% |
| Dec 31, 2021 | 35 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Gossamer Bio | 162 |
| Adicet Bio | 102 |
| Cardiff Oncology | 31 |
| NeurAxis | 24 |
| LeonaBio | 19 |
| MAIA Biotechnology | 13 |
| Alterity Therapeutics | 9 |
RLYB News
- 27 days ago - Rallybio to acquire Avenzo Therapeutics through merger transaction - TheFly
- 27 days ago - Rallybio Transcript: M&A announcement - Transcripts
- 27 days ago - Rallybio Press release: M&A announcement - Filings
- 27 days ago - Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement - Business Wire
- 3 months ago - Rallybio Annual report: Q4 2025 - Filings
- 4 months ago - Rallybio, Candid Therapeutics announce merger agreement - TheFly
- 4 months ago - Rallybio Transcript: M&A announcement - Transcripts
- 4 months ago - Rallybio Press release: M&A announcement - Filings